Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysisLidwien P Smabers, Maarten A Huismans, Niels van Nieuwenhuijzen, et al.Cancers|October 27, 2022
External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily PracticePatricia A H Hamers, G Emerens Wensink, Maarten van Smeden, et al.Npj Biomedical Innovations|April 24, 2026
Accelerating personalized medicine: miniaturized patient-derived organoid drug screening for predicting cancer treatment responses and beyondYasmine Abouleila, Lidwien P Smabers, Timo Voskuilen, et al.Iscience|November 24, 2025
Impact of treatment history on drug resistance of metastatic colorectal cancer organoidsMaarten A Huismans, Lidwien P Smabers, Sascha R Brunner, et al.Oncogene|November 7, 2025
Clinical implications of whole genome sequencing in metastatic colorectal cancerLidwien P Smabers, Hilde H Nienhuis, Wendy W J de Leng, et al.Science (New York, N.Y.)|May 16, 2024
DNA damage induces p53-independent apoptosis through ribosome stallingNicolaas J Boon, Rafaela A Oliveira, Pierré-René Körner, et al.Journal of Experimental & Clinical Cancer Research : CR|February 28, 2024
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient responseLidwien P Smabers, Emerens Wensink, Carla S Verissimo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2025
Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal CancerLidwien P Smabers, G Emerens Wensink, Carla S Verissimo, et al.Pageof 1